Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction
Pharmaceutics · 16.01.2024 · 16 (1) · 115
DOI: 10.3390/pharmaceutics16010115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 16.01.2024. Verfasst von Elena O Bakhrushina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov Universit…. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In modern pharmaceutical technology, modified-release dosage forms, such as in situ formed implants, are gaining rapidly in popularity. These dosage forms are created based on a configurable matrix consisting of phase-sensitive polymers capable of biodegradation, a hydrophilic solvent, and the active substance suspended or dissolved in it. The most used phase-sensitive implants are based on a biocompatible and biodegradable polymer, poly(DL-lactide-co-glycolide) (PLGA).
Objective
This systematic review examines the reasons for the phenomenon of active ingredient “burst” release, which is a major drawback of PLGA-based in situ formed implants, and the likely ways to correct this phenomenon to improve the quality of in situ formed implants with a poly(DL-lactide-co-glycolide) matrix. Data sources: Actual and relevant publications in PubMed and Google Scholar databases were studied. Study selection: The concept of the review was based on the theory developed during literature analysis of 12 effectors on burst release from in situ forming implants based on PLGA. Only those studies that sufficiently fully disclosed one or another component of the theory were included.
Results
The analysis resulted in development of a systematic approach called the “12 Factor System”, which considers various constant and variable, endogenous and exogenous factors that can influence the nature of ‘burst release’ of active ingredients from PLGA polymer-based in situ formed implants. These factors include matrix porosity, polymer swelling, LA:GA ratio, PLGA end groups, polymer molecular weight, active ingredient structure, polymer concentration, polymer loading with active ingredients, polymer combination, use of co-solvents, addition of excipients, and change of dissolution conditions. This review also considered different types of kinetics of active ingredient release from in situ formed implants and the possibility of using the “burst release” phenomenon to modify the active ingredient release profile at the site of application of this dosage form.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia.
ORCID-Profile: Elena O Bakhrushina, Polina S Sakharova, Polina D Konogorova, Victor S Pyzhov, Svetlana I Kosenkova, Irina M Zubareva, Ivan I Krasnyuk
Zitieren
APA
Bakhrushina, E. O., Sakharova, P. S., Konogorova, P. D., Pyzhov, V. S., Kosenkova, S. I., Bardakov, A. I., Zubareva, I. M., Krasnyuk, I. I., & Krasnyuk, I. I. (2024). Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction. Pharmaceutics, 16(1), 115. https://doi.org/10.3390/pharmaceutics16010115
Vancouver
Bakhrushina EO, Sakharova PS, Konogorova PD, Pyzhov VS, Kosenkova SI, Bardakov AI, et al. Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction. Pharmaceutics. 2024;16(1):115. doi:10.3390/pharmaceutics16010115
BibTeX
@article{Bakhrushina2024,
author = {Bakhrushina, Elena O and Sakharova, Polina S and Konogorova, Polina D and Pyzhov, Victor S and Kosenkova, Svetlana I and Bardakov, Alexander I and Zubareva, Irina M and Krasnyuk, Ivan I and Krasnyuk, Ivan I},
title = {Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {1},
pages = {115},
doi = {10.3390/pharmaceutics16010115}
}
EUVIMED